DEC 29, 2018 2:13 PM PST

Kidney Disease Risk Variant Found in New Populations

WRITTEN BY: Carmen Leitch

While we all carry the same genes in our genome, small variations within those genes can cause huge biological changes. Advances in DNA technology, computational tools, and the huge numbers of people whose genomes have been sequenced are allowing scientists to learn more about the effects of gene variants. One such variant in the APOL1 gene had been thought to only impact African-Americans, causing an increase in the risk of kidney disease. New work shows that the variant also affects Latinos and Hispanics. The findings have been reported in The New England Journal of Medicine, and will help clinicians provide better care to patients who are in those groups.

"APOL1 is the poster child for precision medicine, as the risk variants have a large impact on lifetime risk for not only kidney disease but also early onset hypertension and cardiovascular disease," said Eimear Kenny, Associate Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, Director of the Center for Genomic Health, and study senior author. 

The National Kidney Association estimates that around ten percent of the global population is impacted by kidney disease. African-Americans have a roughly 7.5% lifetime risk of developing end-stage kidney disease, compared to about 2% for European-Americans. Much of that risk is due to APOL1 variants. 

Researchers decided to look beyond those communities and found that APOL1 is also affecting Hispanic and Latino populations, likely due to an ancestral connection they have with Africa.

"This finding is crucial in early detection of at-risk individuals who may not be indicated for genetic screening due to self-reporting of ethnic origins, but may still be at high risk due to the presence of APOL1 risk variants," said the first author of the report, Girish Nadkarni, Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. "It is important to more fully understand the global distribution of these variants based on country of origin and genetic ancestry rather than self-reported race/ethnic group."

Now that APOL1 has been revealed as a risk factor in these new groups, physicians will be able to turn their attention to that disease. It will also enable clinicians to establish a connection to the research community so that we can learn more about APOL1 variants in different populations.

"Here at Mount Sinai, we are leading national efforts to learn about the impact of APOL1 risk variants in routine clinical settings, and the gene is currently under intense scrutiny as a therapeutic target and across diverse populations," added Kenny. 


Sources: UPI via The Mount Sinai Hospital, Seminars in Nephrology, NEJM

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 14, 2020
Genetics & Genomics
JAN 14, 2020
Genetic Study Reveals Drug Targets for Several Diseases
Some genetic mutations are due to a change in only one base of the genetic code, while others involve large regions of the genome....
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Epigenetic Changes Make Breast Cancer Cells Drug Resistant
Researchers have found that changes in the structure of the genome in breast cancer cells can make them resistant to drug therapies....
FEB 12, 2020
Microbiology
FEB 12, 2020
Using Genomics to Learn More About a Mumps Outbreak
Though vaccination rates are high, small mumps outbreaks sometimes still occur....
FEB 22, 2020
Genetics & Genomics
FEB 22, 2020
46,000-Year-Old Bird Recovered From Siberian Permafrost
In 2018 in a place called Belaya Gora in northeastern Siberia, a frozen bird was found in the ground. A sample of DNA was recovered from the bird....
MAR 08, 2020
Genetics & Genomics
MAR 08, 2020
Zigzagging DNA
Cells have to store the entire genome in the nucleus, and this lengthy DNA molecule has to be carefully packaged by proteins to fit properly inside....
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood....
Loading Comments...